PCI is a respected industry leader and trusted partner providing a comprehensive range of outsourced pharmaceutical services from early stage development to long term commercial supply
U.S. Serialization Deadline
DEADLINE FOR COMPLIANCE HAS ARRIVED, WE CAN HELP!
We are industry leaders in product security for global medicines with significant Serialization and Anticounterfeiting technologies. Find out how our experienced teams can work with you to understand your exact requirements to ensure your product’s integrity and protect patient safety.
PCI Pharma Services is pleased to announce the completion of our acquisition of Sherpa Clinical Packaging (Sherpa)...
Sherpa’s packaging, labeling, distribution, temperature-controlled storage and returns services are highly complementary to PCI and adding this key geography further strengthens our ability to support existing and new customers.
PCI has launched a new Webflow App and it's available now
Webflow is a market leading technology providing a comprehensive customer support portal which brings many benefits to our clients including access to a wide range of reports updated in real time and available 24/7, enabling more efficient and effective supply management.
Core services include: Analytical services, formulation development, clinical trial services, commercial manufacturing and packaging, QP services, supply chain management, storage and distribution. Customers may choose to use us as a complete development partner and benefit from our full range of services or choose any of our core services as a stand-alone offering.
PCI is pleased to announce the completion of a dedicated Returns Management facility at our Clinical Services Center of Excellence at Bridgend, in the UK. The development reinforces our ongoing investment in and expansion of our global Clinical Services network, reflecting our long-term commitment to ensuring successful Clinical study outcomes for clients
Sherpa’s packaging, labeling, distribution, temperature-controlled storage and returns services are highly complementary to PCI and adding this key geography further strengthens our ability to support existing and new customers.
PCI is pleased to announce the completion of a purpose built -40°C storage and distribution facility at our North American Clinical Services Center of Excellence.
Mr. Haffar joins PCI with over 22 years of experience in the pharmaceutical industry, and currently serves as President of Aptar Pharma and a member of AptarGroup’s senior executive committee.
PCI Pharma Services is pleased to announce the installation and validation of our latest comprehensive Serialization system, located at our manufacturing Center of Excellence in Tredegar, UK.
Expansion of Controlled Substance Storage to Support Blister Packaging Capacity for Opioids
PCI stands ready to support packaging changes brought in by new Opioid legislation PCI Is pleased to announce further investment... View Article
PCI Brexit Communication, 16 January 2019
The UK Parliament voted on 15th January 2019 rejecting the EU/UK Brexit deal and therefore, a number of unknown variables... View Article
We support DEA Schedule I-V controlled substances for both commercial prescription medicines, as well as those for… twitter.com/i/web/status/10880…
x
